Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Carta

Showing results (41-50 of 273) with videos related to

Pageof 28
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 28, 2012
New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform IIFabrizio Carta, Daniela Vullo, Alfonso Maresca, et al.
Journal of Medicinal Chemistry|December 27, 2023
Novel Drug Screening Assay for <i>Acanthamoeba castellanii</i> and the Anti-Amoebic Effect of Carbonic Anhydrase InhibitorsSusanna Haapanen, Harlan Barker, Fabrizio Carta, et al.
Current Eye Research|October 12, 2022
Vasodilation of Pre-contracted Porcine Retinal Arteries by Carbonic Anhydrase Inhibitors with Enhanced LipophilicityThor Eysteinsson, Andrea García-Llorca, Andrea Angeli, et al.
Bioorganic & Medicinal Chemistry|October 27, 2015
New natural product carbonic anhydrase inhibitors incorporating phenol moietiesAnastasia Karioti, Mariangela Ceruso, Fabrizio Carta, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 25, 2017
Synthesis of an acridine orange sulfonamide derivative with potent carbonic anhydrase IX inhibitory actionMarco Bragagni, Fabrizio Carta, Sameh M Osman, et al.
Expert Opinion on Therapeutic Patents|April 24, 2020
A deadly spillover: SARS-CoV-2 outbreakMattia Mori, Clemente Capasso, Fabrizio Carta, et al.
Chemical Communications (Cambridge, England)|June 27, 2012
Polypharmacology of sulfonamides: pazopanib, a multitargeted receptor tyrosine kinase inhibitor in clinical use, potently inhibits several mammalian carbonic anhydrasesJean-Yves Winum, Alfonso Maresca, Fabrizio Carta, et al.
Bioorganic & Medicinal Chemistry|March 29, 2017
Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogsFabrizio Carta, Daniela Vullo, Sameh M Osman, et al.
Organic & Biomolecular Chemistry|May 16, 2015
Dendrimers incorporating benzenesulfonamide moieties strongly inhibit carbonic anhydrase isoforms I-XIVFabrizio Carta, Sameh M Osman, Daniela Vullo, et al.
Chemical Biology & Drug Design|June 25, 2009
Carbonic anhydrase inhibitors: inhibition of cytosolic carbonic anhydrase isozymes II and VII with simple aromatic sulfonamides and some azo dyesFabrizio Carta, Blessy Pothen, Alfonso Maresca, et al.
Pageof 28

Showing results (41-50 of 273) with videos related to

Sort By:
Pageof 28
Bioorganic & Medicinal Chemistry Letters|February 28, 2012
New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform IIFabrizio Carta, Daniela Vullo, Alfonso Maresca, et al.
Journal of Medicinal Chemistry|December 27, 2023
Novel Drug Screening Assay for <i>Acanthamoeba castellanii</i> and the Anti-Amoebic Effect of Carbonic Anhydrase InhibitorsSusanna Haapanen, Harlan Barker, Fabrizio Carta, et al.
Current Eye Research|October 12, 2022
Vasodilation of Pre-contracted Porcine Retinal Arteries by Carbonic Anhydrase Inhibitors with Enhanced LipophilicityThor Eysteinsson, Andrea García-Llorca, Andrea Angeli, et al.
Bioorganic & Medicinal Chemistry|October 27, 2015
New natural product carbonic anhydrase inhibitors incorporating phenol moietiesAnastasia Karioti, Mariangela Ceruso, Fabrizio Carta, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 25, 2017
Synthesis of an acridine orange sulfonamide derivative with potent carbonic anhydrase IX inhibitory actionMarco Bragagni, Fabrizio Carta, Sameh M Osman, et al.
Expert Opinion on Therapeutic Patents|April 24, 2020
A deadly spillover: SARS-CoV-2 outbreakMattia Mori, Clemente Capasso, Fabrizio Carta, et al.
Chemical Communications (Cambridge, England)|June 27, 2012
Polypharmacology of sulfonamides: pazopanib, a multitargeted receptor tyrosine kinase inhibitor in clinical use, potently inhibits several mammalian carbonic anhydrasesJean-Yves Winum, Alfonso Maresca, Fabrizio Carta, et al.
Bioorganic & Medicinal Chemistry|March 29, 2017
Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogsFabrizio Carta, Daniela Vullo, Sameh M Osman, et al.
Organic & Biomolecular Chemistry|May 16, 2015
Dendrimers incorporating benzenesulfonamide moieties strongly inhibit carbonic anhydrase isoforms I-XIVFabrizio Carta, Sameh M Osman, Daniela Vullo, et al.
Chemical Biology & Drug Design|June 25, 2009
Carbonic anhydrase inhibitors: inhibition of cytosolic carbonic anhydrase isozymes II and VII with simple aromatic sulfonamides and some azo dyesFabrizio Carta, Blessy Pothen, Alfonso Maresca, et al.
Pageof 28